# Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-rituximab-in-children-with-difficult-to-treat-nephrotic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Atul Sinha,Divya Bhatia,Ashima Gulati,Meenakshi Rawat,Amit Kumar Dinda,Parameswaran Hari,A. Bagga |
| Citations | 92 |
| DOI | 10.1093/ndt/gfu267 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://academic.oup.com/ndt/article-pdf/30/1/96/17171589/gfu267.pdf |
| OpenAlex ID | https://openalex.org/W2140164312 |
| PMID | 25121488 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Ashima Gulati](https://scholariq.org/researchers/ashima-gulati/)

## Paper journal

- [Nephrology Dialysis Transplantation](https://scholariq.org/journals/nephrology-dialysis-transplantation/)

## Paper primary topic

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Paper topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.